2025 was the transition year. 2026 will be the rebalancing year. That’s Inc42’s thesis for the upcoming year, where we expect ...
Objectives The use of economic evidence to prioritise vaccines and delivery strategies to optimally use in immunisation systems is becoming a global priority, especially in low- and middle-income ...